Melissa K. Carpenter
Directeur/Bestuurslid bij The International Society for Stem Cell Research
Actieve functies van Melissa K. Carpenter
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The International Society for Stem Cell Research | Directeur/Bestuurslid | 18-03-2021 | - |
Loopbaan van Melissa K. Carpenter
Eerdere bekende functies van Melissa K. Carpenter
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Private Equity Investor | 22-09-2010 | - |
| CytoTherapuetics, Inc. | Corporate Officer/Principal | - | - |
CyThera, Inc.
 CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
| GERON CORPORATION | Corporate Officer/Principal | - | - |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | - |
Opleiding van Melissa K. Carpenter
| University of California, Irvine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Finance | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
CyThera, Inc.
CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Commercial Services |
| CytoTherapuetics, Inc. | Finance |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
| The International Society for Stem Cell Research |
